CABRINI’S COVID-19 RESPONSE
We currently have precautionary measures in place to protect our patients and staff. Read more

2024 Cabrini Research Forum

View and vote poster event

Cabrini Research Forum

Learn about the latest research being undertaken at Cabrini and in collaboration with other institutions.

The research posters have been categorised based on the topic of research being undertaken. Expand each category below to view the posters and download a PDF to read more about the project. A summary of all poster categories, research titles and the presenting authors can be downloaded below.

On behalf of Professor Gary Richardson OAM and the Cabrini Research Forum team we would like to thank everyone who showcased their cutting-edge research and participated by voting this year. We received 44 abstracts spanning 12 research areas.

All judges agreed the calibre of research posters was extremely high. The scoring was very tight, in many cases less than one mark separated a lot of excellent posters in each category.

Download a summary of all research posters – 2024

Congratulations to the winners

Thank you again for participating in this event. We congratulate everyone on the exceptional research they are doing, and we hope to welcome you at next year’s event.

  • Yajat Dua – Student undertaking medical research scholarship or honours degree (Colorectal Cancer, poster 20)
  • Harrison Boka – Student undertaking higher degree study – Masters or PhD (Colorectal Cancer, poster 19)
  • Arthavan Surendran – Clinician stepping into research (Colorectal Cancer, poster 23)
  • Eveline Mu – Early career researcher (Women’s Mental Health, poster 44)
  • Shayanti Mukherjee – Mid career researcher (Gynaecology and Obstetrics, poster 28)
  • Eva Zopf – Experienced researcher/Lead researcher award (Cancer – Exercise Therapy, poster 9)
  • Rachel Lim – People’s choice award (Cardiology, poster 15)
  • Alison Blazey – Lucky voter prize

View the posters by research category

The impact of cause of mismatch repair deficiency and other molecular markers on clinical outcomes with the use of durvalumab in advanced endometrial cancer in the phase 2 PHAEDRA trial (ANZGOG1601).

– Yoland Antill

Preliminary results from a first-in-human trial of AMT-116, a topoisomerase I inhibitor containing antibody-drug conjugate (ADC), in patients with advanced solid tumours.

– Gary Richardson

MYE Symphony: A first-in-human study to investigate the safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of the in vivo mRNA CAR therapy, MT-302, targeting TROP2 in adults with advanced epithelial tumours.

– Gary Richardson

Efficacy and safety of LM-108, an anti-CCR8 monoclonal antibody, in combination with an anti-PD-1 antibody in patients with gastric cancer: Results from phase 1/2 studies.

– Gary Richardson

A phase 1 / 2, first-in-human, open label, dose-escalation study of TAK-280, an investigational B7-H3 x CD3ε conditional bispecific redirected activation (COBRA) T-cell engager, in adult patients with unresectable, locally advanced or metastatic solid tumours.

– Garry Richardson

A Phase 1b Study to Evaluate HMBD 001 in combination with Docetaxel with or without Cetuximab in participants with advanced squamous non-small cell lung cancers, and HMBD 001 in combination with Cetuximab in participants with advanced squamous cell cancers.

– Gary Richardson

Cross-over adjusted overall survival for Amivantamab plus chemotherapy vs chemotherapy in first-line EGFR Exon-20 insertion NSCLC.

– Gary Richardson

Deciphering improved clinical therapeutic index (TI) of Muzastotug (ADG126), a masked anti-CTLA-4 SAFEbody® over its unmasked form (ADG116) as monotherapy or in combination with anti-PD-1 therapy.

– Gary Richardson

Structured exercise improves fatigue and health-related quality of life in patients with metastatic breast cancer.

– Eva Zopf

Complications of catheter ablation for atrial fibrillation: important differences in patients with heart failure with systolic heart failure.

– Rose Crowley

Diagnosis to ablation time in persistent AF patients in the CAPLA trial: Any time can be a good time to ablate.

– Rose Crowley

Patterns of atrial fibrillation recurrence in patients undergoing catheter ablation for persistent atrial fibrillation: implications for quality of life and health care utilisation.

– Rose Crowley

Persistent atrial fibrillation phenotypes and ablation outcomes: Persistent from outset vs progression from paroxysmal AF.

– Rose Crowley

Incidence of Post operative Atrial Fibrillation in Patients Post Non-cardiac and Non-thoracic Surgery and the utility of Holter Monitors.

– Roopa Das

Arterial switch operation for transposition of the great vessels – what about the coronary arteries?

– Rachel Lim

Relationship between Titin and lifestyle risk factors on incident AF risk among the UK Biobank.

– Louise Segan

Impact of catheter ablation on valvular remodeling in patients with AF with left ventricular systolic dysfunction.

– Louise Segan

WITHDRAWal of Heart Failure Pharmacotherapy in Patients with Normalized Left Ventricular Ejection Fraction After AF Rhythm Control in AF-mediated Cardiomyopathy – The WITHDRAW-AF Randomized Trial.

– Louise Segan

Unravelling the side-dependent chemotherapy response of colorectal cancer using a patient-derived organoid model.

– Harrison Boka

Surgical Crossroads: How chronic kidney disease alters colorectal cancer surgery outcomes.

– Yajat Dua

Utilisation of the Cabrini Monash University Department of Surgery Tissue Microarray platform in collaborative research projects.

– Christine Georges

A comparison of surgery alone versus surgery plus adjuvant chemotherapy in stage III colon cancer: Utilisation of tissue microarrays to elucidate BRAF and dMMR status in understanding real-world patient cohorts and outcomes.

– Christine Georges

The survival paradox – comparing prognostic outcomes in patients with late stage II and early stage III colorectal cancer.

– Arthavan Surendran

A clinician-friendly dynamic nomogram to evaluate the obesity paradox in colorectal cancer survival outcomes.

– Simon Wilkins

Does BMI influence adverse postoperative outcomes following colorectal cancer surgery?

– Simon Wilkins

Rational engineering and design of 3D printed meshes for biofunctional assessment for pelvic reconstructive surgery: A pre-clinical assessment.

– David Hennes

Regenerative potential of human endometrial mesenchymal stem cells in sheep with simulated vaginal birth injury.

– David Hennes

Foreign body response to implanted human fascial lata in a mouse model: Implications for enhancing pelvic reconstructive surgery.

– Shayanti Mukherjee

Sacrocolpopexy with Fascia Lata: a 1-year follow-up.

– Sascha Vereeck

Pre-hospital extracorporeal cardiopulmonary resuscitation: models of care and a narrative review.

– Karim Khalil and Ethan Erikson

Patient manual handling training. Are we wasting our time?

– Helen Kugler

Australian healthcare workers’ perspectives, practices, and perceived barriers to a more sustainable health system: a cross-sectional survey.

– Philip Russo

Perioperative nursing shortages: An integrative review of their impact, causal factors, and mitigation strategies.

– Ada Xie

Investigating the effect of enhanced cleaning and disinfection of shared medical equipment on health-care-associated infections in Australia (CLEEN): a stepped-wedge, cluster randomised, controlled trial.

– Philip Russo

Impact of receiving guideline concordant treatment on quality of life for people diagnosed with lung cancer: an Australian registry cohort study using patient-reported outcomes to drive value-based healthcare.

– Gary Richardson

Overall survival and patterns of care for women with rare ovarian cancers: A prospective study from the Australian National Gynae-Oncology Registry (NGOR).

– Gary Richardson

Patterns of ovarian cancer care and overall survival in Australia: A prospective study from the National Gynae-Oncology Registry (NGOR).

– Gary Richardson

Comparison of oxycodone SR and tapentadol SR in patients with CABG and/or valvular surgery.

– Seo Hyeon Jeong

Infusion reaction to anticancer therapy – is management optimised?

– Lexi Lim

Cancer-Induced Bone Pain: use of the Edmonton Classification System for Cancer Pain and Management of Refractory Pain.

– Merlina Sulistio

Use of PSMA PET/CT to assist patient selection for focal therapy.

– Darren Lam

Melbourne Urological Research Alliance: Turning patient tumours into tools for studying prostate cancer.

– Melissa Papargiris

Bazedoxifene plus conjugated estrogen to treat menopausal depression – a pilot study.

– Eveline Mu

Clozapine Safety in Pregnancy – A Clinical Study

– Eveline Mu